Information  X 
Enter a valid email address

Antisoma plc (SRC)

  Print      Mail a friend       Annual reports

Wednesday 10 May, 2006

Antisoma plc

Antisoma to present at the Rodman and Renshaw c...

10 May 2006, London, UK - Cancer drug developer Antisoma plc  (LSE:
ASM; USOTC: ATSMY) today announces that Glyn Edwards, its Chief
Executive Officer, will  present at the  Rodman and Renshaw 3rd
Annual Global Healthcare Conference on Tuesday 16 May at 13:00 CET in
Monte Carlo.

A webcast of the presentation will be available on Antisoma's website It is recommended that viewers log on 15 minutes
early in order to register and download any necessary software. A
recorded replay of the presentation will be available after the


Margherita Lupi                            +44 (0)20 8799 8200
Communications Manager

Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products
for the treatment of cancer. Antisoma fills its development pipeline
by acquiring promising new product candidates from internationally
recognised academic or cancer research institutions. Its core
activity is the preclinical and clinical development of these drug
candidates. Antisoma has a broad strategic alliance with Roche to
develop and commercialise products from its pipeline. Please visit for further information.